Page last updated: 2024-08-25

rosiglitazone and oligonucleotides

rosiglitazone has been researched along with oligonucleotides in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chun, J; Daviaud, D; Grès, S; Guigné, C; Pradère, JP; Saulnier-Blache, JS; Simon, MF; Valet, P; Wabitsch, M	1
Artunc, F; Desch, M; Friedrich, B; Mayer, S; Schreiber, A; Schubert, T; Todorov, VT	1

Other Studies

2 other study(ies) available for rosiglitazone and oligonucleotides

Article	Year
Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2. The Journal of biological chemistry, 2005, Apr-15, Volume: 280, Issue:15 Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Animals; Blotting, Western; Carrier Proteins; Cell Differentiation; Cell Line; Cell Proliferation; Culture Media, Serum-Free; Down-Regulation; Fatty Acid-Binding Proteins; Glucose-6-Phosphate Isomerase; Glycoproteins; Humans; Hypoglycemic Agents; Lysophospholipids; Male; Mice; Mice, Knockout; Mice, Transgenic; Monocytes; Multienzyme Complexes; Oligonucleotides; Phosphodiesterase I; Phosphoenolpyruvate Carboxykinase (GTP); Phosphoric Diester Hydrolases; PPAR gamma; Pyrophosphatases; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors; Transcription, Genetic; Triglycerides	2005
PPARgamma-dependent regulation of adenylate cyclase 6 amplifies the stimulatory effect of cAMP on renin gene expression. Molecular endocrinology (Baltimore, Md.), 2010, Volume: 24, Issue:11 Topics: Adenylyl Cyclases; Animals; Base Sequence; Binding Sites; Cell Line; Consensus Sequence; Cyclic AMP; Drug Synergism; Enzyme Activators; Gene Expression Regulation; Humans; Introns; Mice; Molecular Sequence Data; Oligonucleotides; Pioglitazone; Pituitary Adenylate Cyclase-Activating Polypeptide; PPAR gamma; Promoter Regions, Genetic; Renin; Rosiglitazone; Thiazolidinediones	2010

Article

Year

Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.

The Journal of biological chemistry, 2005, Apr-15, Volume: 280, Issue:15

Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Animals; Blotting, Western; Carrier Proteins; Cell Differentiation; Cell Line; Cell Proliferation; Culture Media, Serum-Free; Down-Regulation; Fatty Acid-Binding Proteins; Glucose-6-Phosphate Isomerase; Glycoproteins; Humans; Hypoglycemic Agents; Lysophospholipids; Male; Mice; Mice, Knockout; Mice, Transgenic; Monocytes; Multienzyme Complexes; Oligonucleotides; Phosphodiesterase I; Phosphoenolpyruvate Carboxykinase (GTP); Phosphoric Diester Hydrolases; PPAR gamma; Pyrophosphatases; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors; Transcription, Genetic; Triglycerides

2005

PPARgamma-dependent regulation of adenylate cyclase 6 amplifies the stimulatory effect of cAMP on renin gene expression.

Molecular endocrinology (Baltimore, Md.), 2010, Volume: 24, Issue:11

Topics: Adenylyl Cyclases; Animals; Base Sequence; Binding Sites; Cell Line; Consensus Sequence; Cyclic AMP; Drug Synergism; Enzyme Activators; Gene Expression Regulation; Humans; Introns; Mice; Molecular Sequence Data; Oligonucleotides; Pioglitazone; Pituitary Adenylate Cyclase-Activating Polypeptide; PPAR gamma; Promoter Regions, Genetic; Renin; Rosiglitazone; Thiazolidinediones

2010